NALIRIFOX+Adebrelimab+PULSAR for Advanced Pancreatic Cancer

Clinical trial NCT07595172 · RECRUITING

Trial details

NCT number: NCT07595172
Sponsor: West China Hospital
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Pancreatic Ductal Adenocarcinoma (PDAC)Locally Advanced and Metastatic Pancreatic Cancer

Start date: 2026-04-01
Primary completion: 2028-08-01
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.